NCT03932136: Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) |
|
|
| Recruiting | 3 | 300 | RoW | Sulforaphane, ZHIYINGUOSU, Placebo | Shanghai Jiao Tong University School of Medicine, Shanghai Xuhui District Mental Health Center, Shanghai Pudong Nanhui Mental Health Center, Suzhou Psychiatric Hospital, Second Xiangya Hospital of Central South University, Guangzhou Psychiatric Hospital, Shenzhen Fushan Biotech Co., Ltd., Tianjin Anding Hospital, The First Affiliated Hospital of Zhengzhou University, Shenzhen Kangning Hospital | Clinical High Risk Syndrome of Psychosis | 12/25 | 12/26 | | |
NCT06532058: Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia |
|
|
| Recruiting | 2 | 53 | RoW | QHRD107 capsule，Venclexta and Azacitidine, CDK9 inhibitors | Changzhou Qianhong Bio-pharma Co., Ltd. | Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) | 02/25 | 05/25 | | |
NCT04853485: Repetitive Transcranial Magnetic Stimulation in Early Psychosis and The Functional Connectivity Biotypes |
|
|
| Recruiting | N/A | 300 | RoW | repetitive transcranial magnetic stimulation (rTMS) | Shanghai Jiao Tong University School of Medicine, Suzhou Psychiatric Hospital, Guangzhou Psychiatric Hospital, Shenzhen Kangning Hospital, Tianjin Anding Hospital, Nantong Fourth People's Hospital & Nantong Brain Hospital | Schizophrenia; Psychosis, First Episode Psychosis, Clinical High Risk | 12/23 | 12/24 | | |
